On this page

What the operation aims to do

Microsurgical resection aims to remove the nidus and disconnect the abnormal arteriovenous shunt. Successful complete removal can achieve the anatomical treatment goal immediately, unlike the delayed response expected after radiosurgery. Confirmation of the actual result is still needed. An intended complete resection and a documented complete angiographic result are different statements.1

The operation involves access through the skull and work close to blood vessels and brain tissue. Planning considers the relationship of the nidus to functioning tissue and the feeding and draining vessels, along with any hemorrhage and other treatment already performed.1

Selection is part of the treatment

An AVM that is easier to reach and separate from important tissue can pose different operative risks from a deep or diffuse lesion. Spetzler-Martin and supplementary assessments help specialists estimate surgical risk and discuss selection; they cannot decide the operation in isolation. A low surgical grade is not a guarantee of safety, and a higher grade is not a personal bleeding prediction.23

Whether a lesion has ruptured also changes the setting. Emergency care for hemorrhage and elective resection planning are not interchangeable. Age, existing neurological function, health, symptoms and the person's priorities belong in the discussion. The relevant alternatives include active observation and, in appropriate cases, embolization or radiosurgery.1

Potential benefits and harms

The main anatomical benefit is complete removal of the shunt. Risks include bleeding and new neurological injury, which may affect movement, language, vision or other functions according to the tissue involved. Recovery and the possibility of lasting deficits matter alongside the ability to remove the lesion. Institutional surgical series reflect selected patients, anatomy and expertise; they do not supply a universal success rate.1

For adults with previously untreated unruptured AVMs, ARUBA's randomized comparison favored medical management alone for death or symptomatic stroke during the final reported follow-up. It mixed intervention strategies and was not a trial of surgery alone. A proposed operation therefore needs a patient-specific rationale that discusses the trial honestly, without presenting a selected surgical series as a randomized refutation.4

The role of embolization and result confirmation

Embolization may be used before resection to help selected operations, but it is not automatically necessary for every AVM. Its benefit must be weighed against its own procedural risks. If a staged plan is proposed, ask about the goal and risks of each stage and what happens if the next stage is delayed or cannot proceed.1

Post-treatment vascular assessment checks whether shunting remains. A residual lesion is remaining AVM after treatment; recurrence is a lesion identified after prior documented obliteration. Even after successful angiographic confirmation, recurrence can occur, particularly in younger patients. The confirmation method and age group matter when interpreting follow-up evidence.15

Removal is not the same as recovery

An angiogram showing obliteration cannot establish recovery from an earlier brain injury, seizure freedom or a guarantee against lifetime recurrence. Ask the team to report anatomical result, new deficits, functional recovery and seizure outcomes separately. Ask how its own results were collected for patients similar in age, rupture status and lesion type, and what follow-up is planned.

References

  1. De Leacy R et al. J NeuroIntervent Surg. 2022;14:1118–1124. doi:10.1136/neurintsurg-2021-018632. Source ↩
  2. Derdeyn CP et al. Stroke. 2017;48:e200–e224. doi:10.1161/STR.0000000000000134. Official Top Things to Know summary. Source ↩
  3. Graffeo CS et al. Neurosurgery. 2020;87:442–452. doi:10.1093/neuros/nyaa004. Source ↩
  4. Mohr JP et al. Lancet Neurol. 2020;19:573–581. doi:10.1016/S1474-4422(20)30181-2. PubMed ↩
  5. Järvelin P et al. Neurosurg Rev. 2023;46:99. doi:10.1007/s10143-023-02001-8. Source ↩